中图分类号:
R95
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] BIBLIOGRAPHY Associa??o Nacional das Farmácias (Portugal). (January de 2020). Coronavírus 2019-nCoV: Interven??o da farmácia. Fonte: https://www. revistasauda. pt/SiteCollectionDocuments/ANFOnline/Fluxograma_CEDIMEFinal. pdf
[2] Centers for Disease Control and Prevention. (31 de January de 2020). 2019 Novel Coronavirus-Frequently asked questions and answers. Fonte: https://www. cdc. gov/coronavirus/2019-ncov/faq. html
[3] Centers for Disease Control and Prevention. (31 de January de 2020). How 2019-nCoV Spreads. Acesso em 1 de February de 2020, disponível em CDC-2019 Novel Coronavirus: https://www. cdc. gov/coronavirus/2019-ncov/about/transmission. html
[4] Centers for Disease Control and Prevention. (31 de January de 2020). Interim Guidance for Healthcare Professionals. Acesso em 1 de February de 2020, disponível em CDC-2019 Novel Coronavirus: https://www. cdc. gov/coronavirus/2019-nCoV/hcp/clinical-criteria. html#foot1
[5] Centers for Disease Control and Prevention. (2 de February de 2020). Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Patients Under Investigation (PUIs) for 2019 Novel Coronavirus (2019-nCoV). Fonte: https://www. cdc. gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens. html
[6] Centers for Disease Control and Prevention. (3 de February de 2020). Interim Infection Prevention and Control Recommendations for Patients with Confirmed 2019 Novel Coronavirus (2019-nCoV) or Patients Under Investigation for 2019-nCoV in Healthcare Settings. Fonte: https://www. cdc. gov/coronavirus/2019-ncov/hcp/infection-control. html
[7] Centers for Disease Control and Prevention. (s. d. ). Three Key Factors Required for a Respirator to be Effective. Fonte: https://www. cdc. gov/niosh/npptl/pdfs/KeyFactorsRequiedResp01042018-508. pdf
[8] 赵荣生,杨毅恒,杨丽,等. 新型冠状病毒感染:医院药学工作指导与防控策略专家共识[J].中国药学杂志,2020,55(4):268-277.
[9] LI F. Structure, Function, and Evolution of Coronavirus Spike Proteins. Annual Review of Virology, 3(1), 237-261. doi:10. 1146/annurev-virology-110615-042301
[10] Michelle L. Holshue, M. C. -C. (31 de January de 2020). First Case of 2019 Novel Coronavirus in the United States. New England Journal of Medicine, NA. doi:DOI: 10. 1056/NEJMoa2001191
[11] Ministry of Health of New Zealand. (3 de February de 2020). Interim Advice for Health Professionals: Novel Coronavirus (2019-nCoV). Fonte: https://www.health.govt.nz/system/files/documents/pages/interim_health_advice_for_health_professionals_novel_coronavirus_wuhan_2020_02_03. pdf
[12] Chen N S (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet, NA. Acesso em 4 de February de 2020, disponível em https://www. thelancet. com/journals/lancet/article/PIIS0140-6736(20)30211-7/fulltext
[13] Rothe C. (30 de January de 2020). Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. Fonte: New England Journal of Medicine-Correspondence: https://www. nejm. org/doi/full/10. 1056/NEJMc2001468
[14] Royal Pharmaceutical Society. (January de 2020). Wuhan novel coronavirus-Five key facts for pharmacy teams. Fonte: https://www. rpharms. com/resources/pharmacy-guides/wuhan-novel-coronavirus
[15] World Health Organization. (April de 2010). Guide to Local Production: WHO-recommended Handrub Formulations. Fonte: https://www. who. int/gpsc/5may/Guide_to_Local_Production. pdf
[16] World Health Organization. (28 de January de 2020). Advice on the use of masks in the community, during home care and in health care settings in the context of the novel coronavirus (2019-nCoV) outbreak. Fonte: https://www. who. int/publications-detail/advice-on-the-use-of-masks-the-community-during-home-care-and-in-health-care-settings-in-the-context-of-the-novel-coronavirus-(2019-ncov)-outbreak
[17] World Health Organization. (20 de January de 2020). Home care for patients with suspected novel coronavirus (nCoV) infection presenting with mild symptoms and management of contacts. Fonte: https://www. who. int/publications-detail/home-care-for-patients-with-suspected-novel-coronavirus-(ncov)-infection-presenting-with-mild-symptoms-and-management-of-contacts
[18] World Health Organization. (January de 2020). Novel Coronavirus (2019-nCoV) advice for the public. Fonte: https://www. who. int/emergencies/diseases/novel-coronavirus-2019/advice-for-public
[19] World Health Organization. (January de 2020). Novel Coronavirus (2019-nCoV) advice for the public: Myth busters. Fonte: https://www. who. int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/myth-busters
[20] World Health Organization. (27 de January de 2020). Novel Coronavirus(2019-nCoV)-Situation report 7. Fonte: https://www. who. int/docs/default-source/coronaviruse/situation-reports/20200127-sitrep-7-2019--ncov. pdf
[21] World Health Organization. (9 de January de 2020). Q&A on coronaviruses. Fonte: https://www. who. int/news-room/q-a-detail/q-a-coronaviruses
[22] World Health Organization. (27 de January de 2020). Updated WHO advice for international traffic in relation to the outbreak of the novel coronavirus 2019-nCoV. Fonte: https://www. who. int/ith/2019-nCoV_advice_for_international_traffic/en/
[23] World Health Orzanization. (25 de January de 2020). Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected: interim guidance. Fonte: https://www. who. int/publications-detail/infection-prevention-and-control-during-health-care-when-novel-coronavirus-(ncov)-infection-is-suspected-20200125
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}